VAERS 1653366
SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ325AA
- Staat
- IN
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 29.08.2021
- Impfdatum
- 10.08.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LL
Symptomtext
received expired dose of Pentacel with no reported adverse event; Initial information regarding an unsolicited valid non-serious case was received from the other health care professional via Medical Information (Reference number- 00722325) and transmitted to Sanofi on 12-Aug-2021. This case was linked to case-2021SA270105 (cluster). This case involves a four-month-old female patient who received an expired dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for prophylactic vaccination. On 10-Aug-2021, the patient received a second dose (0.5ml) of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot number: UJ325AA; expiry date: 13-Jun-2021) via intramuscular route in the left thigh for prophylactic vaccination. It was case of actual medication error due to expired vaccine used (latency: same day). It was reported, "Caller states that 2 patients received expired doses of PENTACEL in the practice on 10AUG2021 and 11AUG2021 respectively. Caller asked about how to proceed after administering expired doses to these patients." No adverse events were reported at the time of this report. At the time of this report, the outcome of the event was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- PREVNAR 13
- Allergien
- -
- Vorherige Impfungen
- -